EUVIMEDEUVIMED entdecken
Studienprotokoll

An Ex Vivo Mini-Tumor Culture Protocol for Evaluating Individualized Efficacy of Chemotherapy and Immunotherapy

Yuanfeng Fu, Yuxia Zou, Zhilong Chen, Chenglong Zheng, Dongmeng Liu, Tingting Duan, Jinlong Huang, Xuejun Zhou, Jiaolin Bao, Xiaofeng Wang, Ren-Bo Ding iD

Tissue Engineering Part C: Methods · 01.03.2026 · 32 (3) · 90-98

DOI: 10.1177/19373384261431824 ↗

Kurz gefasst

Studienprotokoll in der Zeitschrift Tissue Engineering Part C: Methods, online erschienen am 11.03.2026. Verfasst von Yuanfeng Fu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Tropical Biological Resources of Ministry of Education, Collaborative Innovation Center of Life and Health, School of Pharmaceutica…. Hauptthemen laut MEDLINE: Immunotherapy, Precision Medicine, Antineoplastic Agents, Neoplasms. Die Arbeit nennt 31 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Conventional drug screening models face a series of challenges in guiding individualized cancer treatment, including time-consuming processes, limited drug coverage, and insufficient accuracy in efficacy evaluation. This study aims to establish a convenient, rapid, and reliable drug screening protocol for evaluating individualized efficacy of chemotherapy and immunotherapy. We established an ex vivo mini-tumor culture platform by culturing tumor fragments in an air–liquid interface system, which was capable of sustaining tumor growth for at least 2 weeks and maintaining immune cell infiltration for over 1 week. Using this mini-tumor culture platform, we can evaluate the individualized therapeutic responses of different tumors to chemotherapy and immunotherapy, including gemcitabine, 5-fluorouracil, cisplatin, αPD-1 and αPD-L1. Furthermore, using this drug evaluation platform, we revealed distinct therapeutic responses to immunotherapy between immune-cold tumors and immune-hot tumors, and demonstrated the important role of the immunologic adjuvant resiquimod (R848) in enhancing immunotherapy efficacy. This mini-tumor culture protocol provides a feasible implementation approach for ex vivo personalized drug testing.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ImmunotherapyPrecision MedicineAntineoplastic AgentsNeoplasmsAnimalsHumansFemaleMiceCell Line, TumorDrug Screening Assays, Antitumor

Stichwörter der Autor:innen

drug screeningimmunotherapyindividualized medicinemini-tumor culturetumor fragments

Substanzen

Antineoplastic Agents

Autor:innen und Institutionen

  • Key Laboratory of Tropical Biological Resources of Ministry of Education, Collaborative Innovation Center of Life and Health, School of Pharmaceutical Sciences, Hainan University, Haikou, China.
  • Department of Otolaryngology-Head and Neck Surgery, the First Affiliated Hospital of Hainan Medical University, Haikou, China.

ORCID-Profile: Ren-Bo Ding

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Fu, Y., Zou, Y., Chen, Z., Zheng, C., Liu, D., Duan, T., Huang, J., Zhou, X., Bao, J., Wang, X., & Ding, R. B. (2026). An Ex Vivo Mini-Tumor Culture Protocol for Evaluating Individualized Efficacy of Chemotherapy and Immunotherapy. Tissue Engineering Part C: Methods, 32(3), 90-98. https://doi.org/10.1177/19373384261431824

Vancouver

Fu Y, Zou Y, Chen Z, Zheng C, Liu D, Duan T, et al. An Ex Vivo Mini-Tumor Culture Protocol for Evaluating Individualized Efficacy of Chemotherapy and Immunotherapy. Tissue Engineering Part C: Methods. 2026;32(3):90-98. doi:10.1177/19373384261431824

BibTeX
@article{Fu2026,
  author = {Fu, Yuanfeng and Zou, Yuxia and Chen, Zhilong and Zheng, Chenglong and Liu, Dongmeng and Duan, Tingting and Huang, Jinlong and Zhou, Xuejun and Bao, Jiaolin and Wang, Xiaofeng and Ding, Ren-Bo},
  title = {An Ex Vivo Mini-Tumor Culture Protocol for Evaluating Individualized Efficacy of Chemotherapy and Immunotherapy},
  journal = {Tissue Engineering Part C: Methods},
  year = {2026},
  volume = {32},
  number = {3},
  pages = {90--98},
  doi = {10.1177/19373384261431824}
}
Kostenlos starten →